 | Morris Karmazyn - 1996 - 538 páginas
...endothelial cells and protects isolated ischemic rat hearts. J Mol Cell Cardiol 1992; 24: 909 19. 32. Linz W, Wiemer G. Gohlke P. Unger T. Scholkens BA....Contribution of kinins to the cardiovascular actions of angiotensin converting enzyme inhibitors. Pharmacol Rev 1995; 47(1): 25 49. 33. Rett K. Lotz N, Wickelmayer... | |
 | Zweten - 1997 - 558 páginas
...evidence. Circ Res 68: 905-92L Linz, W., Wiemer, G., Gohlke, P., Unger, T. and Scholkens, BA (1995). Contribution of kinins to the cardiovascular actions...angiotensin-converting enzyme inhibitors. Pharmacol Rev 47: 25-49. Lonn, EM, Ysuf, S..Jha, P., Montague, TJ, Teo, KK, Benedict, CR and Pitt, B. (1994). Emerging... | |
 | Sami I. Said - 1998 - 760 páginas
...Orlando, FL: Grune & Stratton: 145-159. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. (1995). Contribution of kinins to the cardiovascular actions...angiotensin-converting enzyme inhibitors. Pharmacol Rev 47:25-49. Linz W, Wiemer G, Scholkens BA. (1996). Role of kinins in the pathophysiology of myocardial... | |
 | Alvaro Puga, Kendall Wallace - 1998 - 604 páginas
...species: Implications in atherogenesis. J Toxicol Environ Health, 29:369-388. 1990. 60. Linz W, Wiemar G, Gohlke P. Unger T, Scholkens BA. Contribution of...angiotensin-converting enzyme inhibitors. Pharmacol Rev, 47:25-49, 1995. 61. Yoo JS, Norman JO, Busbee DL. Benzo(a)pyrene uptake by serum lipids: Correlation... | |
 | Mancia Giuseppe - 2000 - 200 páginas
...J. A new enzyme leading to direct formation of angiotensin II. Circ Res 1994:34(suppl l):1203-9. 11. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA....angiotensinconverting enzyme inhibitors. Pharmacol Rev 1995:47:25-49. 1 2. Pals DT, Mascucci FD, Denning GS, Sipos F, Fessler DC. Role of the pressor action... | |
 | Heinz Rupp, Bernhard Maisch - 2000 - 252 páginas
...cardiac hypertrophy in angiotensin II type 1 A receptor knockout mice. Circulation 97: 1952-1959, 1998 6. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA:...Contribution of kinins to the cardiovascular actions of angioternsin-con verting enzyme inhibitors. Pharmacol Rev 47: 25-49, 1995 7. Wirth K, Breipohl G, Stechl... | |
 | Klaus von der Helm, Bruce D. Korant, John Chris Dion Cheronis - 2000 - 440 páginas
...granulocyte collagenase. Science 159:1483-1485 Lintz W. Wiemer G. Gohlke P. Unger T. Scholkens BA (1995) Contribution of kinins to the cardiovascular actions...angiotensin-converting enzyme inhibitors. Pharmacol Rev 47:25-49 Madeddu P (1993) Receptor antagonists of bradykinin: a new tool to study the cardiovascular... | |
 | Pedro D'Orléans-Juste, G.E. Plante - 2001 - 202 páginas
...future potential. Cardiovasc Res 28: 146-158 60 Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA (1995) Contribution of kinins to the cardiovascular actions...angiotensin-converting enzyme inhibitors. Pharmacol Rev 47: 25-49 The contribution of ACE to the metabolism of kinins and the effect of ACE inhibitors 143... | |
 | J. F. Cade - 2002 - 406 páginas
...on diabetic nephropathy. N Engl J Med 329: 1456. Luiz W, Wiemer G, Gohlke P et al 1995 Contributions of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47: 25. Pfeffer MA, Lamas GA, Vaughan DE et al 1988 Effect of captopril on progressive ventricular... | |
| |
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47:25-49. 
